医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Taro Announces Joining of CEO

2017年09月02日 AM05:05
このエントリーをはてなブックマークに追加


 

HAWTHORNE, N.Y.

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) announced today that Mr. Uday Baldota has joined the Company as its Chief Executive Officer (“CEO”) effective August 28, 2017. Since December 2016, Mr. Baldota has served as a member of Taro’s Board of Directors (“Taro Board”).

Mr. Baldota replaces Mr. Abhay Gandhi, who served in the role of Interim Chief Executive Officer since January 1, 2017. Mr. Gandhi will continue in his role as Vice Chairman of the Taro Board and as the CEO of the Sun Pharma North America operations.

About Taro

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170901005726/en/

CONTACT

Taro Pharmaceutical Industries Ltd.
Mariano Balaguer, 914-345-9001
VP,
Chief Financial Officer
Mariano.Balaguer@taro.com
or
William
J. Coote,
914-345-9001
AVP, Business Finance, Treasurer and
Investor Relations
William.Coote@taro.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • BioNet and Sartorius’ Company BIA Separations Collaborate on Production Process Development of mRNA Vaccines
  • ZAP Surgical Appoints Industry Veterans to Lead Chinese Market Expansion
  • ZAP Surgical 任命 业 内 资 深人士 领导 中国市 场 的拓展工作
  • 武田创造强劲的2021财年上半年业绩;受14个全球品牌的推动,增长态势有望进一步持续到财年年底
  • Seoul Semiconductor’s SunLike Natural Spectrum LEDs Selected by European Premium Lighting Brand LEDVANCE